Notable Call Options Activity in Progenics Pharmaceuticals

Shares of Progenics Pharmaceuticals

are lower on the session by 0.20%, currently trading at $7.44. The stock has been moving largely higher over the past two months and is currently trading above the 50-day moving average. Options traders are focusing on calls today. The strike seeing the heaviest volume is the January 2012 $7.00 call, which has traded 2,000 times on open interest of 2,036 contracts. Calls are outpacing puts today by 29 to 1. Progenics Pharmaceuticals, Inc. is a biopharmaceutical company focusing on the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.